In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii
Clinical Microbiology and Infection, 05/03/2012
Clinical Article
Vila–Farres X et al. – Studies of mastoparan with time–killing curves showed bactericidal activity at MIC ×8 for both colistin–susceptible and colistin–resistant A. baumannii. In conclusion, mastoparan may be a potential alternative for the treatment of colistin–resistant A. baumannii infections.



